Growth Metrics

West Pharmaceutical Services (WST) Short term Debt (2016 - 2023)

West Pharmaceutical Services has reported Short term Debt over the past 15 years, most recently at $2.2 million for Q3 2023.

  • Quarterly Short term Debt changed 0.0% to $2.2 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Sep 2023, changed 0.0% year-over-year, with the annual reading at $44.2 million for FY2021, 1821.74% up from the prior year.
  • Short term Debt was $2.2 million for Q3 2023 at West Pharmaceutical Services, roughly flat from $2.2 million in the prior quarter.
  • Over five years, Short term Debt peaked at $44.2 million in Q3 2021 and troughed at $2.2 million in Q1 2022.
  • The 5-year median for Short term Debt is $2.3 million (2019), against an average of $7.8 million.
  • Biggest five-year swings in Short term Debt: surged 2200.0% in 2019 and later crashed 95.02% in 2022.
  • Tracing WST's Short term Debt over 5 years: stood at $2.3 million in 2019, then changed by 0.0% to $2.3 million in 2020, then soared by 1821.74% to $44.2 million in 2021, then crashed by 95.02% to $2.2 million in 2022, then changed by 0.0% to $2.2 million in 2023.
  • According to Business Quant data, Short term Debt over the past three periods came in at $2.2 million, $2.2 million, and $2.2 million for Q3 2023, Q2 2023, and Q1 2023 respectively.